Impact of rare structural variant events in newly diagnosed multiple myeloma.
Monika ChojnackaBenjamin T DiamondBachisio ZicchedduEven Holth RustadKylee H MaclachlanMarios PapadimitriouEileen Mary BoylePatrick BlaneySaad Z UsmaniGareth J MorganCarl Ola LandgrenFrancesco MauraPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Overall, we demonstrate the association of rare SVs with aberrant gene expression supporting a potential driver role in myeloma pathogenesis.